Global Market Study on Gamma Knife: Asia to Witness Highest Growth by 2020


  • Published On : Mar-2015 |
  • Pages : 102 Pages |
  • Format :

Radiation therapy is a procedure entailing the precise delivery of high doses of radiation to tumors and other relevant anatomical targets. It involves the usage of sophisticated technology to ablate tumors and other abnormalities with noninvasive procedures and high doses of radiation while minimizing the exposure to surrounding healthy tissues. 

Gamma Knife radiosurgery is a major form of radiation therapy. It is mainly used to treat brain tumors, arteriovenous malformations, trigeminal neuralgia, acoustic neuroma, and pituitary tumors. In Gamma Knife surgery, specialized equipment focuses close to 200 tiny beams of radiation on a tumor or other targeted cells. Each beam has minimal effect on the brain tissue and it delivers strong doses of radiation to the targeted tumor cells for treatment.

Increasing prevalence of cancer, growing aging population, rising number of initiatives undertaken by various government associations, and advanced features of Gamma Knife systems are major drivers of the global Gamma Knife market. On the other hand, stringent regulatory requirements and prolonged approval time for Gamma Knife systems as well as high cost of implementation and shortage of skilled manpower are some major concerns for the global Gamma Knife market.

In terms of geography, North America dominates the global Gamma Knife market due to increasing prevalence of cancer as well as increasing investments by radiosurgery systems manufacturing companies. In addition, increased awareness about Gamma Knife technology for cancer treatment is also boosting the growth of the Gamma Knife market in the region. The U.S. represents the largest market for Gamma Knife, followed by Canada, in North America. In Europe, Germany, France, the U.K., Italy, and Spain hold major shares of the Gamma Knife market. However, Asia represents the fastest growing region in the Gamma Knife market. This is due to increasing prevalence of cancer and growing aging population. In Latin America, rising incidence of cancer and construction of manufacturing and research facilities by many companies is driving the Gamma Knife market in the region.

This report provides in-depth analysis and estimation of the Gamma Knife market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the report. The Gamma Knife market is categorized on the basis of application and geography. Based on the application, the Gamma Knife market is further categorized into brain market metastases, brain tumor, trigeminal neuralgia, arteriovenous malformations, and others. On the basis of geography, the Gamma Knife market report identify analyzes the size and predictions for North America, Europe, Asia, Latin America, and Rest of the World (RoW). 

Radiation therapy is a procedure entailing the precise delivery of high doses of radiation to tumors and other relevant anatomical targets. Gamma Knife radiosurgery is a major form of radiation therapy. It is mainly used to treat brain tumors, arteriovenous malformations, trigeminal neuralgia, acoustic neuroma, and pituitary tumors. In Gamma Knife surgery, specialized equipment focuses close to 200 tiny beams of radiation on a tumor or other targeted cells. These beams deliver strong doses of radiation to targeted tumor cells with refined precision. This effectively means that surrounding healthy tissues are exposed to minimal or no radiation whatsoever.

Globally, the Gamma Knife market is witnessing significant growth due to increasing prevalence of cancer and obesity and growing aging population. In addition, rising number of initiatives undertaken by various government associations and the advanced features of Gamma Knife systems are also driving the growth of the market. However, stringent regulatory requirements and prolonged approval time for Gamma Knife systems and high cost of implementation and shortage of skilled manpower inhibit the growth of the market.

The global Gamma Knife market is anticipated to grow from an estimated USD 526,733.2 thousand in 2014 to USD 651,241.9 thousand by 2020 at a CAGR of 3.6% during the forecast period.

North America is the largest region and Asia represents the fastest growing region in the Gamma Knife market. In terms of application, brain metastases represent the largest and fastest growing segment of this market.

The North American Gamma Knife market is anticipated to grow from an estimated USD 217,115.5 thousand in 2014 to USD 269,995.5 thousand by 2020 at a CAGR of 3.7% during the forecast period.

The global brain metastases are estimated at USD 360,610.2 thousand in 2014 and is expected to reach USD 448,903.1 thousand by 2020, growing at a CAGR of 3.7% during the forecast period.

Some of the major players in the Gamma Knife market:

  • Elekta AB.
  • Varian Medical Systems, Inc.
  • Huiheng Medical, Inc.
  • Cyber Medical Corporation Limited.
  • Masep Infini Global, Inc.
  • Nordion, Inc.
  • Hokai.
  • ET Medical Group.
  • American Shared Hospital Services.

These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Chapter 1 Preface

1.1 Report Description

1.2 Research Methodology 

1.3 Assumptions 

Chapter 2 Market Synopsis

Chapter 3 Porter’s Five Forces Analysis

3.1 Bargaining Power of Suppliers

3.2 Bargaining Power of Buyers

3.3 Threat of New Entrants

3.4 Threat of Substitutes

3.5 Intensity of Rivalry

Chapter 4 Industry Overview

4.1 Market Definition

4.2 Market Drivers

     4.2.1 Increasing prevalence of cancer

     4.2.2 Rising aging population

     4.2.3 Globally rising obesity

     4.2.4 Rising awareness among people about cancer care

     4.2.5 Advanced features of Gamma Knife

4.3 Impact Analysis of Market Drivers

4.4 Market Restraints

     4.4.1 Strict regulatory requirements and long approval time for Gamma Knife systems

     4.4.2 High cost of implementation and shortage of skilled manpower

4.5 Impact Analysis of Market Restraints

4.6 Market Trends

     4.6.1 Increasing usage of stereotactic radiation therapy is gaining popularity in Gamma Knife market

Chapter 5 Global Market Size and Forecast

Chapter 6 Market Size and Forecast by Application

6.1 Brain Metastases

6.2 Brain Tumors

6.3 Trigeminal Neuralgia

6.4 Arteriovenous Malformations

Chapter 7 Market Size and Forecast by Geography

7.1 North America

     7.1.1 Scenario in the U.S.

     7.1.2 Scenario in Canada

7.2 Europe

     7.2.1 Scenario in Germany

     7.2.2 Scenario in France

     7.2.3 Scenario in the U.K.

     7.2.4 Scenario in Italy

     7.2.5 Scenario in Spain

7.3 Asia

     7.3.1 Scenario in China

     7.3.2 Scenario in India

     7.3.3 Scenario in Japan

7.4 Latin America

     7.4.1 Scenario in Brazil

Chapter 8 Competitive Scenario

8.1 Competitive Benchmarking

Chapter 9 Company Profiles

9.1 Elekta AB

     9.1.1 Company overview

     9.1.2 Products and services

     9.1.3 Financial performance

     9.1.4 Key developments

9.2 Varian Medical Systems, Inc.

     9.2.1 Company overview

     9.2.2 Products and services

     9.2.3 Financial performance

     9.2.4 Key developments

9.3 Huiheng Medical, Inc.

     9.3.1 Company overview

     9.3.2 Products and services

     9.3.3 Financial performance

     9.3.4 Key developments

9.4 Cyber Medical Corporation Limited

     9.4.1 Company overview

     9.4.2 Products and services

     9.4.3 Financial performance

     9.4.4 Key developments

9.5 Masep Infini Global, Inc.

     9.5.1 Company overview

     9.5.2 Products and services

     9.5.3 Financial performance

     9.5.4 Key developments

9.6 Nordion, Inc.

     9.6.1 Company overview

     9.6.2 Products and services

     9.6.3 Financial performance

     9.6.4 Key developments

9.7 Hokai

     9.7.1 Company overview

     9.7.2 Products and services

     9.7.3 Financial performance

     9.7.4 Key developments

9.8 ET Medical Group

     9.8.1 Company overview

     9.8.2 Products and services

     9.8.3 Financial performance

     9.8.4 Key developments

9.9 American Shared Hospital Services 

     9.9.1 Company overview 

     9.9.2 Products and services 

     9.9.3 Financial performance

     9.9.4 Key developments


List of Tables

TABLE 1 Market snapshot: Gamma Knife market, 2014 and 2020

TABLE 2 Major types of cancer causing death, 2012

TABLE 3 Drivers for Gamma Knife market: Impact analysis

TABLE 4 Restraints for Gamma Knife market: Impact analysis

TABLE 5 Global Gamma Knife market size, by region, 2010 – 2013 (USD thousand)

TABLE 6 Global Gamma Knife market size, by region, 2014 – 2020 (USD thousand)

TABLE 7 Global Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 8 Global Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 9 Global Gamma Knife treatment for brain metastases market size, by region, 2010 – 2013 (USD thousand)

TABLE 10 Global Gamma Knife treatment for brain metastases market size, by region, 2014 – 2020 (USD thousand)

TABLE 11 Global Gamma Knife treatment for brain tumors market size, by region, 2010 – 2013 (USD thousand)

TABLE 12 Global Gamma Knife treatment for brain tumors market size, by region, 2014 – 2020 (USD thousand)

TABLE 13 Global Gamma Knife treatment for trigeminal neuralgia market size, by region, 2010 – 2013 (USD thousand)

TABLE 14 Global Gamma Knife treatment for trigeminal neuralgia market size, by region, 2014 – 2020 (USD thousand)

TABLE 15 Global Gamma Knife treatment for arteriovenous malformations market size, by region, 2010 – 2013 (USD thousand)

TABLE 16 Global Gamma Knife treatment for arteriovenous malformations market size, by region, 2014 – 2020 (USD thousand)

TABLE 17 The North American Gamma Knife market size, by country, 2010 – 2013 (USD thousand)

TABLE 18 The North American Gamma Knife market size, by country, 2014 – 2020 (USD thousand)

TABLE 19 The U.S. Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 20 The U.S. Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 21 The Canadian Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 22 The Canadian Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 23 The European Gamma Knife market size, by country, 2010 – 2013 (USD thousand)

TABLE 24 The European Gamma Knife market size, by country, 2014 – 2020 (USD thousand)

TABLE 25 The German Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 26 The German Gamma knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 27 The French Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 28 The French Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 29 The U.K. Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 30 The U.K. Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 31 The Italian Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 32 The Italian Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 33 The Spanish Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 34 The Spanish Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 35 The Asian Gamma Knife market size, by country, 2010 – 2013 (USD thousand)

TABLE 36 The Asian Gamma Knife market size, by country, 2014 – 2020 (USD thousand)

TABLE 37 The Chinese Gamma Knife market size, by application, 2010 – 2013 (USD thousand) 

TABLE 38 The Chinese Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 39 The Indian Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 40 The Indian Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 41 The Japanese Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 42 The Japanese Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 43 The Latin American Gamma Knife market size, by country, 2010 – 2013 (USD thousand)

TABLE 44 The Latin American Knife market size, by country, 2014 – 2020 (USD thousand)

TABLE 45 The Brazilian Gamma Knife market size, by application, 2010 – 2013 (USD thousand)

TABLE 46 The Brazilian Gamma Knife market size, by application, 2014 – 2020 (USD thousand)

TABLE 47 Product categories of Elekta AB

TABLE 48 Product Segments of Varian Medical Systems, Inc.

TABLE 49 Product categories of Huiheng Medical, Inc.

TABLE 50 Product categories of Cyber Medical Corporation Limited

TABLE 51 Product categories of Masep Infini Global, Inc.

TABLE 52 Product segments of Nordion, Inc.

TABLE 53 Product categories of Hokai

TABLE 54 Product segments of ET Medical Group

TABLE 55 Product categories of American Shared Hospital Services


List of Figures

FIG. 1 Gamma Knife market: Porter’s five forces analysis

FIG. 2 Major techniques used in radiation therapy

FIG. 3 Comparison between treatment offered by Gamma Knife radiosurgery and traditional radiosurgery

FIG. 4 Aging population in major countries, 2000 – 2050 (% share in the total population)

FIG. 5 Prevalence of overweight and obese males aged 30 years and above, 2005 and 2015 (%)

FIG. 6 Prevalence of overweight and obese females aged 30 years and above, 2005 and 2015 (%)

FIG. 7 Global Gamma Knife market share, by region, by value, 2013

FIG. 8 Global Gamma Knife market share, by application, by value, 2013

FIG. 9 Global Gamma Knife treatment for brain metastases market share, by region, by value, 2013

FIG. 10 Global Gamma Knife treatment for brain tumors market share, by region, by value, 2013 

FIG. 11 Global Gamma Knife treatment for trigeminal neuralgia market share, by region, by value, 2013

FIG. 12 Global Gamma Knife treatment for arteriovenous malformations market share, by region, by value, 2013

FIG. 13 The North American Gamma Knife market share, by country, by value, 2013

FIG. 14 The U.S. Gamma Knife market share, by application, by value, 2013

FIG. 15 The Canadian Gamma Knife market share, by application, by value, 2013

FIG. 16 The European Gamma Knife market share, by country, by value, 2013

FIG. 17 The German Gamma Knife market share, by application, by value, 2013

FIG. 18 The French Gamma Knife market share, by application, by value, 2013

FIG. 19 The U.K. Gamma Knife market share, by application, by value, 2013 

FIG. 20 The Italian Gamma Knife market share, by application, by value, 2013

FIG. 21 The Spanish Gamma Knife market share, by application, by value, 2013

FIG. 22 The Asian Gamma Knife market share, by country, by value, 2013

FIG. 23 The Chinese Gamma Knife market share, by application, by value, 2013

FIG. 24 The Indian Gamma Knife market share, by application, by value, 2013

FIG. 25 The Japanese Gamma Knife market share, by application, by value, 2013

FIG. 26 The Latin American Gamma Knife market share, by country, by value, 2013

FIG. 27 The Brazilian Gamma Knife market share, by application, by value, 2013

FIG. 28 Competitive landscape of Gamma Knife market, 2013

FIG. 29 Elekta AB’s net sales and profit, 2012 – 2014 (USD million)

FIG. 30 Varian Medical Systems, Inc.’s revenue and net earnings, 2012 – 2014 (USD million)

FIG. 31 Nordion, Inc.’s revenue and net income/loss, 2011 – 2013 (USD million)

FIG. 32 Hokai’s revenue and net income, 2011 – 2013 (USD million)

FIG. 33 American Shared Hospital Services’ revenue and net income/loss, 2011 –2013 (USD thousand)

Back To Top